Company / R&D per Share
ESTABLISHMENT LABS HOLDINGS INC. R&D per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.70
FY2025
5-year range
$0.64 / $1.08
FY2021-FY2025
Trend
-6.9%
vs FY2024
Sector context
#79 of 108
Health Care
What the data says
At $0.70, ESTABLISHMENT LABS HOLDINGS INC.'s r&d per share ranks #79 of 108 in the Health Care sector. R&D per Share has fluctuated over the past 9 years, ranging from $0.63 in FY2019 to $1.08 in FY2023.
Based on SEC 10-K filings.
0.70 in FY2025 with a 5-year CAGR of -0.6%.
Declined from $1.08 to $0.70 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -5.8%
- 5-Year CAGR
- -0.6%
- 10-Year CAGR
- -
Sector benchmark
#79 of 108 in Health CareTop 73% of 108This company $0.70 Sector average $2.07
▼
-66.1% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 6.9% year-over-year.
- Ranks #79 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.56 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.70 | -6.9% |
| FY2024 | $0.76 | -30.2% |
| FY2023 | $1.08 | +28.6% |
| FY2022 | $0.84 | +32.0% |
| FY2021 | $0.64 | -12.2% |
| FY2020 | $0.73 | +16.0% |
| FY2019 | $0.63 | -6.7% |
| FY2018 | $0.67 | +0.0% |
| FY2017 | $0.67 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026